Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(23 sites)

Bulgaria

Novartis Investigative Site, Rousse

Novartis Investigative Site, Sevlievo

Novartis Investigative Site, Sofia

Colombia

Novartis Investigative Site, Ibague, Tolima Department

Guatemala

Novartis Investigative Site, Guatemala City, GTM

Novartis Investigative Site, Guatemala City

Hungary

Novartis Investigative Site, Debrecen, Hajdu Bihar Megye

Novartis Investigative Site, Budapest

Novartis Investigative Site, Eger

Novartis Investigative Site, Kaposvár

Novartis Investigative Site, Nagykanizsa

Novartis Investigative Site, Szigetvár

Poland

Novartis Investigative Site, Tarnów

Novartis Investigative Site, Lodz, Łódź Voivodeship

South Africa

Novartis Investigative Site, George, Western Cape

Novartis Investigative Site, Cape Town

Spain

Novartis Investigative Site, Esplugues, Barcelona

Novartis Investigative Site, Sabadell, Barcelona

Novartis Investigative Site, Mérida, Extremadura

Novartis Investigative Site, Barcelona

United Kingdom

Novartis Investigative Site, London

Novartis Investigative Site, Stoke-on-Trent